The in vitro micronucleus (MN) assay is widely used to assess genotoxic potential of the test substances by measuring frequency of MN in cultured mammalian cells. Traditionally, MN frequency has been determined by microscopy. In recent years, a flow cytometric method for enumeration of MN has been developed, which significantly shortens analysis time and enhances assay throughput. However, a major concern has been raised that the MN results obtained from flow cytometry can be impacted by chromatin bodies produced during apoptosis or necrosis. In this work, we further evaluated this flow cytometry-based in vitro MN assay with CHO-K 1 cells in a 24-well platform. Our results showed that the MN frequency determined using the flow cytometric method was highly correlated with the microscopy results. Importantly, several non-genotoxic apoptosis inducers or cytotoxins that have been previously reported to produce 'artificial positives' in various in vitro genotoxicity tests were evaluated in this system. As a result, these nongenotoxic cytotoxins did not produce false-positive MN response in the flow cytometric system in CHO-K 1 cells when cytotoxicity was <50 6 10%. Moreover, a total of 21 compounds were evaluated in this work, including direct or indirect clastogens, aneugens and non-genotoxic chemicals. A sensitivity of 83.3% and a specificity of 100% were obtained from the compounds we tested. Finally, significant increase of incidents in the hypodiploid region, an aneugenic signature, was confirmed in our evaluation. In conclusion, the flow cytometric in vitro MN assay is a reliable method that can be used to detect clastogenic or aneugenic potential of the test substances in CHO-K 1 cells.
Introduction
Micronuclei (MN) are formed from acentric chromosome fragments (i.e. lacking a centromere) or lagging chromosomes that are unable to migrate with the rest of the chromosomes during the anaphase stage of cell division (1, 2) . The MN assay is widely used as a screening assay to predict outcomes from the chromosomal aberration (CA) test due to the advantages of being simpler, faster and requiring less technical expertise (3) (4) (5) (6) . Moreover, the MN assay is capable of detecting aneugens as well as clastogens, which may not be easily detected in the CA (6) . However, the microscopic scoring process is still fairly lengthy and tedious.
Therefore, automation of the in vitro MN assessment is of great interest.
A flow cytometry-based in vitro MN assay has been developed to detect the frequency of MN within a large number of cells in a short period of time (7) . However, potential false-positive response resulting from cytotoxicity or apoptosis may be obtained by flow cytometry, as chromatin fragments derived from apoptotic or necrotic cells can fall in the MN gate (8, 9) . Therefore, a number of different strategies have been employed to improve the specificity of this assay. Roman et al. (10) incorporated a new electronic gating step to remove debris. Litron Laboratories (Rochester, NY, USA) has further developed the assay in which an ethidium monoazide bromide (EMA) prestaining step is included to label the chromatin of necrotic and mid-/late-stage apoptotic cells prior to subsequent dissolution of the plasma membrane and staining of micronuclear DNA (11) (12) (13) .
The flow cytometric in vitro MN assay has been primarily evaluated in suspension cell lines (11) (12) (13) . A recent study reported that this assay can also be applied to attachment cell lines, including CHO-K 1 and V-79 (14) , which are routinely used in the microscopic in vitro MN assay (6, 15) . In this study, we evaluated the flow cytometric in vitro MN assay (MicroFlow Ò by Litron Laboratories) in CHO-K 1 cells, a cell line that is frequently used in standard genotoxicity testing, using an array of genotoxins with various mode of action (MOA), along with several non-genotoxic compounds, including several cytotoxins which have been reported to produce false-positive results in in vitro genotoxicity tests (16) or are capable of inducing apoptosis by various mechanisms. Altogether, 21 well-characterized compounds were used to evaluate this assay, and as a result, the assay was found to yield high sensitivity and specificity. Notably, our top concentration selection strategy was very effective as none of the non-genotoxic apoptosis-inducing chemicals was determined positive. Furthermore, evident hypodiploidy was observed only after treatment with aneugens but not with clastogens or nongenotoxic chemicals. Therefore, we concluded that the flow cytometric method delivers reliable results in MN assessment in CHO-K 1 cells and that it also provides valuable information on test chemicals MOA and multiple cellular parameters such as concurrent cytotoxicity measurement, cell cycle progression and so on.
from MolTox (Boone, NJ, USA). The In Vitro MicroFlow Ò Kit was obtained from Litron Laboratories. The 6-lm fluorescent beads (Cat. no. P14828) were used as counting beads and were obtained from Invitrogen (Carlsbad, CA, USA).
Cell culture CHO-K 1 (Chinese Hamster Ovary cells; American Type Culture Collection, Manassas, VA, USA) were maintained in HAMS-F12 medium (HycloneThermo Fisher Scientific, Logan, UT, USA) supplemented with 10% fetal bovine serum (American Type Culture Collection), 100 U/ml penicillin and 100 lg/ml streptomycin (Gibco-Invitrogen) in a humidified atmosphere with 5% CO 2 at 37°C. For routine cultivation, cells were maintained up to $80% of confluency.
Chemical treatment
One day prior to treatment, logarithmically growing cells were trypsinized and 12 000 cells (ÀS9 treatment) or 20 000 cells (þS9 treatment) were seeded in each well of 24-well plates. The culture medium was aspirated and same volume of fresh medium was added in each well 16-24 h after seeding. Test chemicals were dissolved in aqueous or organic solvent such that the final concentration was 10% v/v for aqueous solvent or 1% v/v for organic solvent. Cells were treated with each test chemical in duplicate wells over a range of concentrations with no more than one or two intervals between adjacent concentrations. A metabolic activation system was prepared in serum-free HAMS-F12 medium consisting of a final S9 concentration of 1.5%, 1.8 mM NADP and 10.5 mM isocitric acid. For the treatment with metabolic activation, cells were treated with a test chemical in the S9 mix medium for 4 h, after which the medium was removed, and cells were washed with Hank's buffered salt solution and incubated with S9-free fresh medium for 24 h. For the treatment without metabolic activation, cells were incubated with test chemical continuously for 28 h at 37°C. Cyclophosphamide (for treatment with metabolic activation) and mitomycin C (MMC) (for treatment without metabolic activation) served as concurrent positive controls to ensure the performance of the assay. In all cases, after a total of 28 h since initiation of the treatment, which represents about two cell cycles of CHO-K 1 , cells were processed for microscopic scoring or flow cytometric MN analysis.
Microscopic scoring of MN Cells were seeded and treated in slide chambers (NUNC-Thermo Fisher Scientific) as described above. At the completion of treatment, cells were washed with phosphate-buffered saline, swollen with 0.075 M KCl for ,1 min and fixed in cold methanol and allowed to air-dry. The slides were then stained with acridine orange and scored using a microscope equipped with blue excitation filter (440-490 nm) with a barrier filter combination at 520 nm at Â1000 magnification using oil immersion. In total, 1000 cells from each culture (2000 cells per dose level) were scored for the presence of MN. The %MN results in the experiment comparing MN results scored by microscopy and flow cytometry were analyzed by Fisher's exact test.
Flow cytometric enumeration of MN
A sequential staining method was applied to the treated samples according to the In Vitro MicroFlow Kit manual. Essentially, upon the completion of test chemical treatment, cells were first stained with a photo-activated dye, Dye 1 (EMA) and then washed, lysed and stained with lysis solutions containing RNase, nucleic acid Dye 2 (SYTOX Green) and the counting beads. DNA from apoptotic/necrotic cells with compromised cell membranes was labeled with both EMA and SYTOX Green, which can be distinguished from EMA-negative and SYTOX Green-positive MN. As the same amount of counting beads were added to each well, nuclei (EMA-negative) to beads ratio was used to calculate relative survival (RS) as a cytotoxicity measurement.
Samples were analyzed with a BD FACSCantoä II flow cytometer. Data acquisition and analysis were accomplished with FACSDiva 6.0. Strategies for acquiring flow cytometric data, including configuration of regions and gating logic, were as described in the In Vitro MicroFlow Kit manual and as described by Avlasevich et al. (11) . Briefly, SYTOX-associated fluorescence emission was collected in the fluorescein isothiocyanate channel (530/30), and EMAassociated fluorescence was collected in the PerCP-Cy5.5 channel (695/40). Events were gated as shown in Figure 1 . The incidence of MN was determined through the acquisition of $10 000 gated healthy nuclei (EMAÀ/SYTOXþ) per well. The counting beads were collected simultaneously in a separate plot ( Figure 1G ). In addition, the SYTOX fluorescence histogram showed the cell cycle progression profile ( Figure 1B) , and the hypodiploid gate was used to determine whether aneuploidy was induced ( Figure 1F ).
Top concentration selection and data evaluation Chemicals were tested up to 5 mg/ml or 10 mM unless limited by solubility or cytotoxicity, with the exception of sodium chloride, which was tested .10 mM. RS value is calculated as (mean of nuclei/beads in treated samples)/(mean of nuclei/beads of solvent control) Â 100%. If cytotoxicity is the limiting factor, the top concentration was selected when producing 50 AE 10% in RS if possible.
A test compound was deemed positive if both of the following criteria were met:
Mean %MN values were above the solvent historical control range. Mean %MN values were !2-fold increase compared with the concurrent solvent control values.
A test compound was deemed negative if at least one of the criteria above is not satisfied.
Caspase-3/7 activation assay The Caspase-3/7 activation kit was obtained from Promega (Madison, WI, USA) and the assay was performed according to the manufacturer's protocol. Essentially, a parallel 24-well plate was treated as described above; cells were trypsinized and resuspended in 500 ll of fresh medium. A total of 100 ll of cell suspension from each sample was mixed with 100 ll of reconstituted reagent and the mixture was then incubated at room temperature for 30 min. The produced bioluminescence signal was measured in a Tecan Safire 2 spectrophotometer (Tecan, Männedorf, Switzerland). Caspase-3/7 activation was expressed as a fold change of the solvent control.
Results

Comparison of microscopic analysis and flow cytometric analysis
To directly compare MN results from microscopic scoring and flow cytometric analysis, we treated the CHO-K 1 cells with a well-characterized clastogen, MMC or an aneugen, vinblastine (VB), in slide chambers (for microscopy) and 24-well plates (for flow cytometric analysis) at three to four relevant concentrations. Test concentration selection was based on RS (refer to Materials and methods) from flow cytometry. Figure 2 shows that %MN values obtained from microscopy and flow cytometry were highly comparable at all concentrations and statistically significant increases of MN frequencies were observed at all four concentrations for MMC and at 0.02 and 0.04 lg/ml for VB by both methods. Notably, VB showed a very 'steep' cytotoxicity profile where 0.08 lg/ml yielded only 20% RS (supplementary data, available at Mutagenesis Online), thus the next concentration, 0.04 lg/ml, was selected as the top concentration for MN evaluation.
MN results from flow cytometry were not interfered by apoptosis or cytotoxicity Previous studies reported that MN frequencies measured by flow cytometry could be interfered by the chromatin fragments produced during apoptosis (8, 9) . We examined three nongenotoxic apoptosis inducers (dexamethasone, tunicamycin and staurosporine) with various mechanisms (Table I) and two chemicals (2,4-dichlorophenol and phthalic anhydride) that had previously produced 'false-positive' results in in vitro genotoxicity tests (16) , using this flow cytometric MN assay. Since the false-positive results were reported in the conditions without metabolic activation (9, 16) , these chemicals were only tested in the ÀS9 system here. As shown in Figure 3 , none of these five chemicals produced significant increase of MN frequencies determined by the flow cytometric assay.
In order to examine whether apoptosis was indeed induced by dexamethasone, tunicamycin or staurosporine at the concentrations tested for MN frequencies, we conducted an independent experiment in which samples treated by each of these apoptosis inducers were examined for Caspase-3/7 activation, a biomarker detecting the onset of apoptosis. As shown in Table I , at 0.005 and 0.01 lg/ml, staurosporine treatment induced a statistically significant activation of Caspase-3/7 (t-test, P , 0.05). However, positive MN response (!2-fold of concurrent solvent control value) was only observed at 0.01 lg/ml, where RS was ,40%. Therefore, this concentration was considered as a toxic concentration and should not be included for MN assessment. For dexamethasone and tunicamycin, Caspase-3/7 in the treated samples was not activated at the tested concentrations, suggesting that they did not induce apoptosis under these conditions even though RS was reduced to $40% (Table I) , although it is likely that Caspase-3/7 activation occurred at an earlier time point and did Ò kit (Litron Laboratories) procedures. Events must meet the following criteria in order to be scored as nuclei, hypodiploid or MN: the events must fall within light scatter plots (A); to be at least 1/100 of the SYTOX-associated fluorescence (FITC) as G1 nuclei (B); within SSC versus FITC region (C); within FSC versus FITC region (D) and to be EMA-negative (E). The MN gate was set to collect events with 1/100 to 1/10 of the SYTOX-associated fluorescence as G1 nuclei (F). The counting beads were collected simultaneously in a separate plot (G) as 10 000 nuclei were acquired, and nuclei versus beads ratio was used to calculate RS. SSC, side scatter; FSC, forward scatter.
Evaluation of
assay appears to effectively exclude toxic concentrations and that apoptosis does not appear to interfere with MN results using this method in CHO-K 1 cells.
Aneugenicity signature
It has been reported that a population of nuclei that shared the light scatter characteristics and EMA-negative phenotype of healthy nuclei contained reduced SYTOX fluorescence ( Figure 1F ), therefore they were defined as 'hypodiploid' in TK6 and CHO-K 1 cells (12, 14) . In this study, we further confirmed that a drastic increase of hypodiploid events (!10-fold increase compared to the concurrent solvent control) was only observed in samples treated with aneugens but not with non-genotoxic chemicals or clastogens (Figure 4) . Notably, we observed this 'aneugenicity signature' from all four aneugens, VB, colchicine, diethylstilbestrol and nocodazole, tested in this study (colchicine data see supplementary data, available at Mutagenesis Online).
Predictivity of the flow cytometric MN assay A total of 21 chemicals were tested to evaluate the predictivity of the flow cytometric MN assay, which include four direct clastogens, one topoisomerase inhibitor, three indirect clastogens, four aneugens and nine non-genotoxic chemicals. The genotoxic classification of the chemicals was based on information obtained from literature (Table II) . The flow cytometric MN assay yielded a sensitivity (proportion of genotoxic chemicals determined to be positive in the flow cytometric MN assay) of 83.3% and a specificity (proportion of non-genotoxic chemicals determined to be negative in the flow cytometric MN assay) of 100% (Table II) . These results suggested that the flow cytometric method produced reliable results and is suitable as an alternative method to evaluate MN induction in CHO-K 1 cells.
Discussion
Due to its ability to detect aneugens along with other advantages, the in vitro MN assay has been accepted as an alternative or replacement assay for the in vitro CA assay used for hazard identification in genotoxicity testing. Automated scoring approaches such as the In Vitro MicroFlow using flow cytometry or image-based system, e.g. Cellomics (Pittsburgh, PA, USA) have demonstrated promising results to replace the manual evaluation of the MN incidence (14, 27) . In this study, we evaluated the In Vitro MicroFlow Ò MN assay with 21 genotoxic or non-genotoxic chemicals with various mechanisms in CHO-K 1 cells. As shown above, the high sensitivity and specificity of this assay demonstrated in this work led us to conclude that it produces reliable results and can be used to assess genotoxic potential of test chemicals, at least in CHO-K 1 cells (Table II) . The advance in the automated scoring system not only greatly reduces labor and shortens the analysis time but also provides objective analysis and avoids bias from scorers. Moreover, in addition to assessment of MN frequencies and concurrent cytotoxicity, the assay obtains multiple important cellular parameters, including apoptosis/necrosis ratio, hypodiploidy and cell cycle progression, which can help define MOA and cannot be achieved from the traditional microscopy-based assay.
The flow cytometric MN assay is not a simple automation of the standard microscopic assay. There are substantial differences between these two assays. The microscopic MN assay has been conducted for decades using binucleated cells produced by a cytokinesis blocker, cytochalasin B (CytB), although recent validation studies showed evidence to support conducting the study without CytB treatment for cells with high replicative index (18, 22, 28) . The flow cytometric assay also analyzes MN events in samples free of CytB treatment, which allows detecting MN frequencies in cells at a more physiologically relevant state where normal cell cycle progression is intact. Importantly, the microscopy-based assay scores the percentage of micronucleated cells, whereas the flow cytometric assay analyzes MN to healthy nuclei (EMA-negative) ratio. So if the test chemical induces multiple MN in single cells, the results from these two assays could be inconsistent. Given these differences, the results from the two assays were highly comparable (Figure 2) , which supports the use of the flow cytometric method as an alternative to standard microscopy.
A primary concern of using flow cytometry to detect MN is that apoptotic or necrotic bodies could produce false-positive results (8, 9) . Since the MN events determined by flow Evaluation of a flow cytometric in vitro micronucleus assay cytometry are based on light scatter characteristics and fluorescence intensity (SYTOX Green), it is difficult to distinguish the real MN events and the DNA fragments resulting from apoptosis. The EMA gating procedure is capable of removing the events with compromised cell membranes derived from apoptosis or necrosis (11); nevertheless, DNA fragmentation may also occur prior to break down of the plasma membrane in early apoptotic cells. In this case, the EMA gating may not be as effective to separate the apoptotic bodies from the MN.
Collins et al. (9) observed inconsistent results from the flow cytometric MN assay in comparison to the standard microscopy performed in mouse lymphoma cells treated with two non-genotoxic apoptosis inducers, staurosporine and dexamethasone. However, our evaluations of these two chemicals and tunicamycin in CHO-K 1 cells produced clear negative results (Figure 3) . Moreover, there was no significant activation of Caspase-3/7 detected at the tested concentrations for two of the three apoptosis inducers. For staurosporine treatment, apoptosis was indeed induced at 0.005 and 0.01 lg/ml. However, the 0.01 lg/ml concentration can be easily excluded from MN assessment due to the fact that RS was ,40% (acceptable range for top concentration: 50 AE 10%). In addition, no significant increase of MN was observed for staurosporine treatment at 0.005 lg/ml, although there was a modest Caspase-3/7 activation (Table I) . Thus, apoptosis does not appear to interfere with the MN results in CHO-K 1 cells by flow cytometry. The other two non-genotoxic cytotoxins, 2,4-DCP, which had produced false-positive results in the mouse lymphoma assay (MLA), CA (16) and Comet (J. Shi, S. Springer and P. Escobar, submitted for publication), and phthalic anhydride, which was determined 'positive' in MLA and CA (16) , were also determined to be negative in the flow cytometric MN assay. Therefore, our data demonstrated that the flow cytometric MN assay delivers reliable results in CHO-K 1 cells, even when challenged by apoptosis inducers and non-genotoxic cytotoxins. Nevertheless, this could be a cell line-specific characteristic, as CHO-K 1 cells may not be as susceptible to apoptosis inducers as other cell lines, such as human lymphoblast TK6 cells and mouse lymphoma L5178Y, possibly because CHO-K 1 cells express a mutant tumor suppressor, p53 (29, 30) .
In addition, Collins et al. used a Coulter counter-based cytotoxicity measurement in their study that did not take account of cell viability, therefore the top concentration selected by a method that may underestimate cytotoxicity could also contribute to the insistent result observed between the flow cytometric method and the microscopy analysis. The nucleusversus bead-derived RS values used in the flow cytometric assay is an equivalent to relative cell concentration, which measures both cell number and viability (membrane permeability), and appears to be appropriate to select top concentration which renders positive MN results for genotoxic compounds (83.3% sensitivity) and avoids false-positive MN results for non-genotoxic compounds (100% specificity) (Table II) . With a base line measurement, this flow cytometric method can also provide other calculations of cytotoxicity (e.g. relative increased cell concentration and relative population doubling that are under debate of the recent International Workshop on Genotoxicology Testing).
The study design of the flow cytometric MN assay is essentially in line with the Organisation for Economic Cooperation and Development Draft Guideline Document 487. A short-term (3-6 h) treatment in the absence of metabolic activation was not used since we found that the long-term treatment (28 h) was sufficient to detect genotoxic chemicals that do not require metabolic activation in this screening assay. Also, chemicals were tested up to 40-60% RS to reduce unnecessary repeats of the test for screening purpose. Another important feature of this flow cytometric MN assay is that it differentiates clastogenicity and aneugenicity. Bryce et al. (12) reported two aneugenic signatures, increase of hypodiploid events and increase of median SYTOX Green fluorescence of MN. Our data demonstrated the increased occurrence of hypodiploidy as a unique feature for aneugens (Figure 4 ). These hypodiploid events following treatment by aneugens are very likely to represent nuclei that are missing a few chromosomes. However, the increase of median SYTOX Green fluorescence of MN was not evident in all aneugens we evaluated (supplementary data, available at Mutagenesis Online).
There were two genotoxic chemicals, 2-aminoanthracene and 5-fluorouracil, that had previously been identified as clastogens produced negative results in our flow cytometric MN analysis. These two chemicals appear to be weak clastogens as controversial results have been reported. 2-Aminoanthracene induced positive MN results in CHL and V79 cells with S9 activation for 6 and 4 h, respectively (6, 22) . However, in a recent Cellomics-based MN study performed in CHO-K 1 cells, it did not induce a substantial increase of MN in both ÀS9 or þS9 conditions, therefore was judged negative (27) . 5-Fluorouracil was also positive in CHL and L5178Y in one study (6) while it was also found negative without metabolic activation in another study in CHL cells (3) and equivocal in V79 cells (15) . In CHO-K 1 cells, it was classified as weak positive in a Cellomics-based MN assay (27) . So, it is reasonable to argue that these two chemicals may induce a relatively weaker increase of MN in CHO-K 1 cells, where it did not reach the threshold of a positive response in the flow cytometric assay.
In summary, our data demonstrated that the flow cytometric MN assay is a reliable method to assess MN frequencies in CHO-K 1 cells and is especially ideal for screening assays due to the automated scoring procedures and high content results.
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